Mercer Capital provides a broad range of specialized valuation advisory services to the medical technology industry, helping clients by providing independent valuation opinions and transaction advisory assistance. Our services for companies in the medical technology industry include purchase price allocation, impairment testing, equity compensation, tax compliance, litigation support, corporate valuation services, and transaction advisory services.

Each issue of this newsletter typically includes a market overview, mergers and acquisitions review, guideline public company pricing and more.

Industry Segments

This newsletter focuses on the following industry segments:

  • Biotechnology
  • Healthcare Technology
  • Healthcare Supplies
  • Medical Equipment
  • Life Science Tools & Services

Subscribe for email updates


CURRENT ISSUE

Year-End 2016

Article
Pfizer Acquires Medivation: Allocating a Purchase Price for a Biopharma Transaction

IPO Case Study
Crispr Therapeutics

Updated Metrics for Year-End 2016


2016 Issue

2015 Issues

2014 Issues